What is the recommended treatment for acute orchitis?

Treatment of Acute Orchitis

For acute orchitis, treatment depends critically on the underlying etiology: viral orchitis (predominantly coxsackievirus B) requires supportive care only, while bacterial epididymo-orchitis requires immediate empiric antibiotics targeting sexually transmitted or enteric pathogens based on patient risk factors. 1

Distinguish Isolated Orchitis from Epididymo-Orchitis

Isolated orchitis is predominantly viral (77% of cases), with coxsackievirus B strains accounting for 62% of cases. 2 This distinction is critical because:

• Viral orchitis does NOT require antibiotics and is typically self-limiting within days 2, 3
• Bacterial epididymo-orchitis requires immediate antibiotic therapy 1
• Physical examination should assess whether the epididymis and testis are separately palpable—if they are distinct structures, isolated orchitis is more likely 4

Viral Orchitis Management

For confirmed or suspected viral orchitis:

• Supportive care with analgesics is the mainstay of treatment 2, 3
• The disease is usually rapidly self-limiting, with acute symptoms resolving within 2-4 days 2, 5
• Obtain semen PCR for enteroviruses at disease onset (not serum/urine, as virus is not detectable there) 2
• Important caveat: Approximately 30% of patients develop persistent oligozoospermia despite resolution of acute symptoms 2

Mumps Orchitis Specific Considerations

For bilateral mumps orchitis specifically:

• Interferon-alpha 2B (3 × 10⁶ IU/day for 7 days) may prevent testicular atrophy and sterility, though this is based on limited evidence from small case series 5
• This should be considered particularly in bilateral cases where fertility preservation is critical 5

Bacterial Epididymo-Orchitis Management

First-Line Antibiotic Selection Based on Risk Factors

For patients with sexually transmitted pathogen risk (age <35 years, new/multiple sexual partners):

• Ceftriaxone 1 g IM single dose PLUS doxycycline 100 mg orally twice daily for 10-14 days 1
• The 2024 European guideline increased ceftriaxone dosing from 500 mg to 1 g due to rising gonococcal resistance 1
• Dual therapy with azithromycin is no longer recommended unless cefixime substitutes for ceftriaxone 1

For patients with enteric pathogen risk (age >35 years, recent urinary instrumentation, anal intercourse):

• Ofloxacin 200-400 mg orally twice daily OR levofloxacin 500 mg orally once daily for 10-14 days 1
• Use fluoroquinolones as monotherapy when enteric organisms are the primary concern 1

For patients with BOTH sexually transmitted AND enteric pathogen risks:

• Ceftriaxone 1 g IM single dose PLUS either ofloxacin or levofloxacin (doses as above) 1

Duration of Antibiotic Therapy

• 10-14 days total duration is recommended 1
• Extend to 14 days in men when prostatitis cannot be excluded 6

Surgical Intervention Criteria

Surgery is indicated when conservative management fails within 48-72 hours or when specific complications develop. 4

Staging System for Surgical Decision-Making

Stage 1 (E/T+, no hydrocele, no abscess):

• All patients respond to antibiotics alone 4
• Continue conservative management 4

Stage 2 (E/T+, hydrocele present, small/few abscesses):

• 85.4% respond to antibiotics 4
• Proceed to organ-sparing surgery if no improvement within 48-72 hours 4

Stage 3 (no E/T differentiation, malacia, hydrocele, any-sized abscesses):

• Majority require surgery within 48-72 hours due to poor antibiotic response 4
• Obtain cultures of purulent drainage to guide therapy 7

Surgical Approach

• Organ-sparing surgery is preferred when technically feasible 4
• If purulent material is encountered, establish drainage and continue broad-spectrum antibiotics pending cultures 6

Special Pathogen Considerations

Brucella Orchitis (Endemic Areas)

• Consider Brucella in endemic regions, even with atypical presentations 8
• Obtain specific serological tests 8
• Necrotizing/abscess-forming Brucella orchitis may require orchidectomy despite specific antibiotic therapy 8

Critical Pitfalls to Avoid

• Do NOT use azithromycin monotherapy for suspected gonococcal infection due to resistance 9
• Do NOT rely on serum/urine testing for enterovirus detection—only semen PCR is diagnostic 2
• Do NOT delay surgical consultation beyond 72 hours if antibiotics fail to produce clinical improvement 4
• Do NOT assume fertility preservation even with appropriate treatment—counsel patients about 30% risk of oligozoospermia 2

Follow-Up Requirements

• Reassess within 48-72 hours to evaluate treatment response 4
• Obtain semen analysis 2-4 months post-treatment to detect oligozoospermia 2
• Monitor for testicular atrophy during follow-up, particularly after viral orchitis 5